The Risks of Assisting Evolution
By Elizabeth Alter,
The New York Times
| 11. 10. 2015
Untitled Document
THERE are four locked doors guarding a specialized lab at the Harvard School of Public Health. The doors are meant to prevent insects inside the lab from venturing out — which is essential, because researchers behind those doors are re-engineering mosquitoes by cutting and pasting bits of DNA with tools unimaginable a decade ago.
If researchers can figure out the right combination of genes, they’ll manufacture a mosquito resistant to malaria, which could save hundreds of thousands of lives every year. But geneticists, bioethicists and others who understand the implications of this new technology are apprehensive. To an astonishing degree, these new tools, which include a technique called Crispr-Cas9, allow us to bend evolution to our will. But will we harness these new technologies to help our planet? Or spark an ecological catastrophe?
In university labs, corporate R&D centers and even inside amateur D.I.Y. laboratories, researchers are creating genetically modified organisms at an unprecedented pace. This biotechnological revolution is so fast-moving that it hasn’t yet fully filtered into the public’s awareness or policy...
Related Articles
Riquet Mammoth Kakao (c.1920)
by Ludwig Hohlwein, Public Domain via Flickr
Colossal, the de-extinction company, scored headlines (1, 2, 3, 4, 5) recently by announcing that they had created mice! Not just any mice, not even colossal mice, but genetically engineered, normal-size “woolly mice” that are the result of editing seven genes in mouse embryos. This Colossal presented as an important step toward making a specimen of charismatic megafauna – a...
By Ben Johnson, Nature | 02.14.2025
A London-based biotech has amassed the world’s largest ethically sourced foundational biodiversity database for training artificial intelligence (AI) by setting up partnerships with 25 countries around the world. The startup, Basecamp Research, announced in January the launch of a new...
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...